(Q48679924)

14 February 2018

title

Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. (English)

1 reference

14 February 2018

0 references

6

Marc Decramer

1 reference

14 February 2018

Yoshinosuke Fukuchi

1

1 reference

14 February 2018

Lenora Fernandez

2

1 reference

14 February 2018

Han-Pin Kuo

3

1 reference

14 February 2018

Aziah Mahayiddin

4

1 reference

14 February 2018

Bartolome Celli

5

1 reference

14 February 2018

Steven Kesten

7

1 reference

14 February 2018

Dacheng Liu

8

1 reference

14 February 2018

Donald Tashkin

9

1 reference

14 February 2018

publication date

1 July 2011

1 reference

14 February 2018

published in

Respirology

1 reference

14 February 2018

volume

16

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

825-835

1 reference

14 February 2018

Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

COPD in Japan: the Nippon COPD Epidemiology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

COPD in Asia: where East meets West

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Safety of long-acting beta2-agonists in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Clinical phenotypes of COPD: results of a Japanese epidemiological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Effect of low-dose theophylline on airway inflammation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01982.X

10.1111/J.1440-1843.2011.01982.X

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

21539680

1 reference

14 February 2018